Timothy S. Ernst - Feb 28, 2024 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO BIOB)

Role
EVP, General Counsel & Sec
Signature
/s/ Timothy S. Ernst
Stock symbol
BIO BIOB
Transactions as of
Feb 28, 2024
Transactions value $
-$11,000
Form type
4
Date filed
2/29/2024, 05:24 PM
Previous filing
Sep 6, 2023
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO BIOB Bio-Rad A Common Stock Options Exercise $815K +2.5K +73.58% $326.15 5.9K Feb 28, 2024 Direct F1
transaction BIO BIOB Bio-Rad A Common Stock Sale -$826K -2.5K -42.39% $330.55 3.4K Feb 28, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO BIOB Non-Qualified Stock Option (right to buy) Options Exercise $0 -2.5K -100% $0.00* 0 Feb 28, 2024 Bio-Rad A Common Stock 2.5K $326.15 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 13.6810 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/29/2023.
F2 The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 4, 2019, which was the first anniversary of the date on which the option was granted.